{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry Cystatin C_2 Assay (CYSC_2)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K181082",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171072"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NDY"
    ],
    "Summary Letter Date": "May 25, 2018",
    "Summary Letter Received Date": "April 24, 2018",
    "Submission Date": "April 23, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cystatin C"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (lithium heparin)",
        "Plasma (potassium EDTA)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced turbidimetry"
    ],
    "Methodologies": [
        "Turbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens ADVIA Chemistry Cystatin C_2 assay using particle-enhanced turbidimetry for quantitative determination of cystatin C on ADVIA Chemistry systems",
    "Indications for Use Summary": "For in vitro quantitative determination of cystatin C in human serum and plasma on ADVIA Chemistry systems to aid in the diagnosis and treatment of renal disease.",
    "fda_folder": "Clinical Chemistry"
}